The Ibex rises amid a wave of corporate operations and vaccine news
The main event of the week is the Fed meeting
The week starts lively amid multiple corporate operations that are boosting the stock markets (Ibex: + 0.8%; Cac: + 0.8%; Dax: + 0.8%). Asia ended this morning with a dominance of green numbers after the announcement that Oracle has imposed itself on Microsoft and is about to become a technology partner of TikTok. Additionally, chipmaker Nvidia will purchase Arm Holding from SoftBank for $ 40bn. Similarly, it is news that Gilead will take over cancer drug maker Immunomedics for $ 21bn.
IBEX 35
11.674,800
-
0,33%38,90
- Max: 11.674,80
- Min: 11.591,80
- Volume: -
- MM 200 : 11.091,94
News about the vaccine is added to corporate operations this Monday. This weekend, Oxford and AstraZeneca announced that they are resuming the trial of their coronavirus vaccine. In addition, the CEO of Pfizer has stated that his vaccine could be supplied to Americans before the end of the year.
In Spain, people are talking about CaixaBank and Bankia and the difficulties surrounding the merger. According to different media, it is cooling down due to the differences in the exchange equation. Now both entities are expected to approve the merger this week when it was previously scheduled to take place this past weekend.
Investors are going to pay attention these days to what the Federal Reserve (Fed) has to say on Wednesday after its monetary policy meeting. The highlight of this week is the FOMC meeting on Wednesday, the first after the Fed announced its new framework for inflation. We expect a change in direction and an increase in QE buying. We think the Federal Reserve will recognize the importance of creating credibility immediately, especially as inflation expectations remain subdued, "Danske Bank experts point out in their daily report.
Also, a vote in the ruling Japanese Liberal Democratic Party will choose Prime Minister Shinzo Abe's successor on Monday after his resignation for health reasons. Abe's senior cabinet secretary and right-hand man Yoshihide Suga appears poised to win and continue Abe's accommodative economic policy. "Suga is the 'steady hand' candidate. He has no plans to increase the sales tax for another 10 years and supports the Bank of Japan's target of 2% inflation," adds Danske.
